Use of genetic testing to identify sudden cardiac death syndromes

Matteo Vatta1, Katherine G Spoonamore2

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN; Department of Medicine, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN.

Insights

Sudden cardiac death (SCD) is a major global killer. Genetic factors, including complex multi-allelic inheritance, are increasingly recognized as significant contributors to SCD risk beyond traditional causes.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Sudden cardiac death (SCD) is a primary cause of mortality globally.
  • While coronary artery disease is the most common cause, primary genetic heart diseases significantly contribute to SCD.
  • Advances in genetic studies have identified genes linked to cardiomyopathies and arrhythmia syndromes, increasing SCD risk.

Purpose of the Study:

  • To discuss the evolving understanding of genetic predispositions for cardiac diseases.
  • To highlight the shift from a monogenic to a multi-allelic inheritance model in clinical genetics.
  • To address the complexity of genetic factors influencing SCD risk and phenotypes.

Main Methods:

  • Review of genetic studies on family pedigrees.
  • Analysis of advancements in massive parallel sequencing and whole-genome analysis.
  • Discussion of clinical genetic testing paradigms.

Main Results:

  • Discovery of numerous causative genes for primary cardiomyopathies and arrhythmia syndromes.
  • Identification of complex genetic architectures underlying cardiac diseases.
  • Recognition of multi-allelic inheritance patterns modulating disease severity and phenotype.

Conclusions:

  • The genetic basis of cardiac diseases and SCD is more complex than previously understood.
  • Clinical genetic testing must adapt to account for multi-allelic inheritance and gene-environment interactions.
  • Further research and debate are needed to refine genetic diagnostics and risk stratification for SCD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
488
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.9K
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
9.0K